Advertisement

Analysis of ITGB2 rare germline variants in chronic lymphocytic leukemia

Grace Tiao, Ma. Reina Improgo, Eugen Tausch, Stacey M. Fernandes, Jasmin Bahlo, Sandra Robrecht, Kirsten Fischer, Michael Hallek, Stephan Stilgenbauer, Adam Kiezun, Gad Getz and Jennifer R. Brown

Article Information

PubMed 

Print ISSN 
Online ISSN 


Contributors 
  • Grace Tiao, 1 Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States;
  • Ma. Reina Improgo, 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States;
  • Eugen Tausch, 3 Department of Internal Medicine III, Ulm University, Ulm, Germany;
  • Stacey M. Fernandes, 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States;
  • Jasmin Bahlo, 4 Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany;
  • Sandra Robrecht, 4 Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany;
  • Kirsten Fischer, 4 Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany;
  • Michael Hallek, 4 Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany;
  • Stephan Stilgenbauer, 3 Department of Internal Medicine III, Ulm University, Ulm, Germany;
  • Adam Kiezun, 1 Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States;
  • Gad Getz, 5 Center for Cancer Research, Massachusetts General Hospital, Boston, MA, United States
  • Jennifer R. Brown, 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output